MSCI is set to report Q3 2026 earnings on Oct. 20, 2026, with consensus estimates of $4.99 EPS and $880.29M revenue, representing 11.63% and 10.95% YoY growth respectively. The company is expected to benefit from strong demand for index solutions, growing asset-based fees, and accelerating Private Capital Solutions, but faces headwinds from persistent weakness in its Sustainability business and rising operating expenses.

SEI Investments is expected to report Q3 2026 earnings of $1.58 per share (up 21.5% YoY) with revenues of $658.54 million (up 13.8% YoY) on October 21. However, the company has a negative Earnings ESP of -0.16% with a Zacks Rank #3, making it difficult to predict an earnings beat. Despite a strong history of beating estimates in the last four quarters, recent analyst revisions have turned bearish on earnings prospects.

MSCI is expected to report Q3 2026 earnings of $5.00 per share (up 11.9% YoY) with revenues of $879.98 million (up 10.9% YoY) on October 20. The company has a positive Earnings ESP of +0.26% combined with a Zacks Rank #3, suggesting a likely earnings beat. MSCI has beaten consensus EPS estimates in all four of the last quarters.

The article explains how investors can use the Zacks Earnings ESP (Expected Surprise Prediction) metric to identify stocks likely to beat earnings expectations. The ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, and when combined with a Zacks Rank of #3 or better, has historically produced 28.3% annual returns. Two finance stocks highlighted as examples are Palomar (PLMR) with a +1.89% ESP and a #2 Buy rating, and MSCI with a +0.26% ESP and a #3 Hold rating.

The article explains Zacks' Earnings ESP (Expected Surprise Prediction) methodology for identifying stocks likely to beat quarterly earnings expectations. It highlights that combining a positive Earnings ESP with a Zacks Rank #3 or better has historically produced 28.3% annual returns. Two finance stocks are featured as examples: MSCI with a +0.60% ESP ahead of October 20 earnings, and Arch Capital Group with an +8.91% ESP before October 27 earnings.

CME Group and Morningstar are compared as financial infrastructure plays. CME dominates derivatives trading with an impressive 62% net margin and $6.5B revenue, but trades at a premium valuation (forward P/E 22.5). Morningstar offers investment research with lower margins (15.3%) but more attractive valuation (forward P/E 15.5). The author leans toward CME despite valuation concerns due to its superior profitability and dividend, though both stocks have underperformed the S&P 500 over longer periods.

Michael Burry disclosed new short positions on semiconductor stocks, purchasing January 2027 puts on the SOXX semiconductor ETF at a $330 strike price, implying a 27% drawdown. The disclosure coincided with SOXX snapping its historic 18-day winning streak with a 2% decline on Monday. Burry attributes the rally to technical factors rather than fundamentals, noting the index was trading 43% above its 200-day moving average with RSI near 85. The selloff occurred as seven semiconductor companies prepare to report earnings this week.

The article examines conspiracy theories that Morgan Stanley and MSCI orchestrated Bitcoin's Q4 2025 crash to accumulate coins cheaply before launching ETFs. It debunks four main myths by analyzing market mechanics, leverage, macroeconomic factors, and regulatory developments, concluding that while TradFi's crypto embrace creates imbalances favoring institutions, it's not evidence of coordinated manipulation but rather normal market opportunism amid the merger of traditional finance and crypto.

MSCI reported Q2 2025 financial results with revenue of $772.7 million, exceeding expectations. While core segments showed stable growth, the company experienced slower new business, particularly in sustainability and climate products.

Resmed, a global leader in health technology, has appointed Salli Schwartz as its new Chief Investor Relations Officer. Schwartz brings extensive experience from her previous roles at Illumina, MSCI, and Moody's, and will lead Resmed's global investor relations function.

BofA analysts expect mostly in-line or better Q1 earnings for industrial companies, with Q3 flagged as a potential earnings trough. They highlight 3M, Johnson Controls, and GE Vernova as top picks, despite lowering EPS estimates due to tariff uncertainty.

MSCI, a leader in investment decision support tools, reported mixed Q4 earnings. While adjusted EPS beat expectations, revenue fell slightly short. The company saw solid earnings amidst lower net income, driven by the absence of previous period gains. MSCI remains focused on expanding its Index and ESG offerings, though it faces some operational headwinds.